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Cystic fibrosis (CF) is a chronic disease in which the bacterial colonization of the
lung is linked to an excessive inflammatory response that leads to respiratory failure.
The microbiology of CF is complex. Staphylococcus aureus is the first bacterium to
colonize the lungs in 30% of pediatric CF patients, and 80% of adult patients develop
a chronic Pseudomonas aeruginosa infection, but other microorganisms can also be
found. The use of antibiotics is essential to treat the disease, but antibiotic performance
is compromised by resistance mechanisms. Among various mechanisms of transfer
of antibiotic resistance genes (ARGs), the recently been reported bacteriophages are
the least explored in clinical settings. To determine the role of phages in CF as mobile
genetic elements (MGEs) carrying ARGs, we evaluated their presence in 71 CF patients.
71 sputum samples taken from these patients were screened for eight ARGs (blaTEM,
blaCTX−M−1-group, blaCTX−M−9-group, blaOXA−48, blaVIM, mecA, qnrA, and qnrS) in the
bacteriophage DNA fraction. The phages found were also purified and observed by
electron microscopy. 32.4% of CF patients harbored ARGs in phage DNA. β-lactamase
genes, particularly blaVIM and blaTEM, were the most prevalent and abundant, whereas
mecA, qnrA, and qnrS were very rare. Siphoviridae phage particles capable of infecting
P. aeruginosa and Klebsiella pneumoniae were detected in CF sputum. Phage particles
harboring ARGs were found to be abundant in the lungs of both CF patients and healthy
individuals and could contribute to the colonization of multiresistant strains.
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INTRODUCTION
Cystic fibrosis (CF) is the most common autosomal recessive disease in the Caucasian population
(Panitch and Rubenstein, 2010). The important morbidity and mortality of this disease are related
to pulmonary affectation and its complications, which are responsible for up to 85% of the deaths
of patients suffering from CF, including children and adults (Panitch and Rubenstein, 2010; Elborn,
2016).
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The microbiology of CF is complex. Staphylococcus aureus
colonizes the lungs of more than 30% of child or youth patients.
In adolescence, chronic pulmonary infection with Pseudomonas
aeruginosa is developed, which remains in up to 80% of adult CF
patients and is capable of growing in biofilms in the lungs, thereby
greatly complicating antibiotic treatment of the disease. Other
opportunistic pathogens have also been isolated from CF patients,
including Burkholderia cepacia and Haemophilus influenza.
Additional opportunistic pathogens such as Stenotrophomonas
maltophilia, Achromobacter xylosoxidans, and nontuberculous
Mycobacterium are being recovered from adult patients with
increasing frequency (Bittar et al., 2008; Lipuma, 2010).
After the observation that the mucous obstructing CF
airways is hypoxic, analysis under strict anaerobic conditions
has revealed that anaerobic bacterial species are also present
within CF airways in high numbers. The spectrum of facultative
and obligate anaerobic species recovered from CF samples
frequently includes members of the genera Prevotella,
Streptococcus, Rothia, and Veillonella (Fodor et al., 2012).
High throughput sequencing efforts indicate that the CF
microbiome consists of more than 60 different bacterial
genera, while interrogation of bacterial 16S ribosomal RNA
(rRNA) gene-based phylogenetic microarrays has placed the
estimate at as many as 43 different bacterial phyla and over
2,000 different taxa (Guss et al., 2011; Fodor et al., 2012). In
contrast, the role of fungi, viruses and mycobacteria (which are
not identified by standard bacterial 16S rRNA sequencing) is
still unclear (Kim et al., 2015). Pulmonary exacerbations are
related to a complex relationship between host defense and
airway microbiota and can lead to pulmonary decline. Early
recognition and treatment of exacerbations is fundamental for
patient wellbeing, and so frequent monitoring of patients is
necessary.
Antibiotic resistance is a serious global health problem
(Hawkey and Jones, 2009), as infections caused by resistant
pathogens may be difficult to treat. The dispersion of clones
exhibiting resistance to various antibiotics has become common
(Cantón et al., 2005; Czekalski et al., 2012) and represents a
greater threat than ever before (Hawkey, 2008; Hawkey and
Jones, 2009). In the case of CF, the use of antimicrobials is
necessary throughout the life of the patient. Aggressive antibiotic
therapies are already used during primocolonization with the
aim of eradicating the microorganisms in the airway of the
CF patient. The ultimate objective is to delay the deterioration
of lung function that occurs during chronic colonization,
which reduces the quality of life and survival of the patient
(Castellani and Assael, 2017). During chronic colonization,
nebulized, oral, and intravenous chronic suppressive treatments
are used (Cantón et al., 2005; Castellani and Assael, 2017).
All this facilitates resistant or multiresistant antimicrobial
bacteria being selected over time. Some studies suggest that
up to 45% of CF patients are colonized by a multiresistant
microorganism, which makes antimicrobial treatment even
more difficult (McCaughey et al., 2013). Among new proposals
for treating CF infections, phage therapy and co-treatment
with antibiotics is a promising approach that may overcome
antibiotic resistant pathogens and natural resistance in biofilm
(Alemayehu et al., 2012; Saussereau et al., 2014; Fong et al.,
2017).
Transfer of antibiotic resistance genes (ARGs) mediated by
mobile genetic elements (MGEs) provides the most important
and rapid mechanism of dispersion. The most commonly
studied MGEs are plasmids, transposons and, more recently,
bacteriophages (or phages) (Srivastava et al., 2004; Colomer-
Lluch et al., 2011b; Colombo et al., 2016; Lekunberri et al., 2017),
which are bacterial viruses that infect and multiply using the
machinery of the host bacterium.
In the case of CF, phages have been detected in the
metagenome of respiratory tracts of patients (Willner et al.,
2009) and ARGs have been found in the sputum virome of
five patients (Fancello et al., 2011). Phages can be important
contributors to the mobilization of ARGs, leading to the
emergence of new resistant clones, which is a major problem in
the treatment of CF patients. Our objective was to detect and




The study was conducted with 71 sputum samples of 71 CF
patients taken during regular follow up visit to the CF unit of Vall
d’Hebron Hospital in Barcelona, from August 2015 to October
2016. The age of CF patients under study ranged from four to
79 years. All the samples were used only after performing a
conventional microbiological diagnosis and they were completely
anonymized. No data other than the age of the patients were
collected and the samples were destroyed immediately after the
study. The study was approved by the Clinical Research Ethics
Committee of the Hospital (reference number PR(AG)187/2014).
Additionally, 21 sputum samples were taken from a group of
people not suffering from CF who had not received antibiotics
in the previous 3 months.
Bacterial Isolation and Antimicrobial
Susceptibility Characterization
Sputum samples were processed within 2 h of reception. They
were homogenized with 2% cysteine solution (1:1) (v:v) and
vigorously vortexed before being plated in chocolate agar,
mannitol salt agar, MacConkey agar, and modified Thayer-Martin
agar.
Isolates identification was performed using the VITEK
MS matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS) system (bioMérieux,
Marcy-l’Étoile, France) and antimicrobial susceptibility to
β-lactams, quinolones and aminoglycosides of bacterial isolates
was studied by the disk diffusion method following EUCAST
(EUCAST, 2016). Specifically, the antimicrobials evaluated
for non-fermenting gram-negative bacteria were ampicillin-
sulbactam, piperacillin-tazobactam, ceftazidime, cefepime,
aztreonam, imipenem, meropenem, ciprofloxacin, amikacin, and
tobramycin; and for Staphylococcus aureus, penicillin, ampicillin,
cefoxitin and gentamicin.
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Bacteriophage Purification From Sputum
Samples
One ml of each sample was diluted 1:3 in phosphate-buffered
saline (PBS). The suspension was filtered through 0.22 µm
low protein-binding membrane filters (Millex-GP, Millipore,
Bedford, MA, United States). The suspension was then treated
with chloroform (1:10) (v:v) to minimize the presence of
membrane vesicles containing DNA and treated with DNase
(100 units/ml of the phage lysate at 37◦C for 1 h), to remove
non-packaged DNA. The DNase was heat inactivated at 75◦C for
5 min.
Evaluation of the Protocol for Phage
DNA Recovery From Sputum Samples
Assays were performed to verify the efficiency of the protocol
for phage DNA recovery from sputum. Firstly, various degrees
of homogenization of five CF sputum samples negative for
the presence of the blaTEM gene were performed in PBS
(direct analysis, 1:3 dilution and 1:5). In each dilution, 10 µl
of the qPCR standard containing 103 gene copies (GC) of
the blaTEM gene were inoculated. The conditions showing
the best recovery of the GC number were used in the
experiments.
In addition, five CF sputum samples were inoculated to a
final concentration of 106 phage particles/ml with a suspension
of phage 933W (Imamovic et al., 2010). This phage contains one
copy of the Shiga toxin 2 (stx2) gene in its genome and was not
expected to be naturally present in these samples. The stx2 qPCR
assay (Imamovic et al., 2010; Table 1) was used to detect the stx
and each copy corresponded to one phage 933W. Comparison
of the number of phage particles inoculated and the number of
phages 933W recovered from the sputum after phage purification
and DNA extraction allowed the protocol effectiveness to be
calculated.
Phage DNA Extraction
The phage suspensions purified from the samples or from the
enrichment cultures were then digested using proteinase K
(0.5 µg.ml−1), and the DNA extracted with phenol/chloroform
(1:1 v/v) (Sambrook and Russell, 2001). The remaining
phenol/chloroform was removed by adding the mixture to
Phase Lock Gel Tubes (5-Prime, Hucoa Erlöss, Madrid, Spain)
and centrifuging following the manufacturer’s instructions.
TABLE 1 | Quantitative real time PCR primers and probes for qPCR assays used in this study.
Target gene PCR Sequence Amplimer (bp) Reference
blaTEM qPCR UP CACTATTCTCAGAATGACTTGGT 85 Lachmayr et al., 2009
LP TGCATAATTCTCTTACTGTCATG
Probe 6FAM-CCAGTCACAGAAAAGCATCTTACGG-MGBNFQ
blaCTX−M−1 qPCR UP ACCAACGATATCGCGGTGAT 101 Colomer-Lluch et al., 2011b
LP ACATCGCGACGGCTTTCT
Probe 6FAM – TCGTGCGCCGCTG-MGBNFQ
blaCTX−M−9 qPCR UP ACCAATGATATTGCGGTGAT 85 Colomer-Lluch et al., 2011a
LP CTGCGTTCTGTTGCGGCT
Probe 6FAM – TCGTGCGCCGCTG-MGBNFQ
blaOXA−48 qPCR UP CGGTAGCAAAGGAATGGCAA 133 Brown-Jaque et al., 2018
LP TGGTTCGCCCGTTTAAGATT
Probe 6FAM – CGTAGTTGTGCTCTGGA-MGBNFQ
blaVIM qPCR UP AATGGTCTCATTGTCCGTGATG 61 This study
LP TACAGCGTGGGGTGCGA
Probe 6FAM –TGATGAGTTGCTTTTGATTG-MGBNFQ
mecA qPCR UP CGCAACGTTCAATTTAATTTTGTTAA 92 Volkmann et al., 2004
LP TGGTCTTTCTGCATTCCTGGA
Probe 6FAM-AATGACGCTATGATCCCAATCTAACTTCCACA-MGBNFQ
qnrA qPCR UP AGGATTGCAGTTTCATTGAAAGC 138 Colomer-Lluch et al., 2014b
LP TGAACTCTATGCCAAAGCAGTTG
Probe 6FAM-TATGCCGATCTGCGCGA-MGBNFQ
qnrS qPCR UP CGACGTGCTAACTTGCGTGA 118 Colomer-Lluch et al., 2014b
LP GGCATTGTTGGAAACTTGCA
Probe 6FAM –AGTTCATTGAACAGGGTGA-MGBNFQ
stx2 UP ACGGACAGCAGTTATACCACTCT 65 Imamovic et al., 2010
LP CTGATTTGCATTCCGGAACGT
Probe FAM-CCAGCGCTGCGACACG-NFQ
16S rDNA UP 28f AGAGTTTGATCCTGGCTCAGA 1503 Weisburg et al., 1991
Eubacteria LP 1492r TACGGCTACCTTGTTACGACTT
qPCR, quantitative real time PCR; UP, upper primer; LP, lower primer; MGBNFQ, Minor groove binding non-fluorescent quencher; FAM: 6-carboxyfluorescein reporter.
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DNA was precipitated using 100% ethanol and 3M sodium
acetate, and resuspended in 50 µl of ultrapure water. DNA
was quantified using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Thermo Fisher Scientific, Wilmington,
DE, United States). To verify the absence of non-packaged DNA,
the protocol for DNA extraction from the phage fraction of
the samples was always accompanied by several controls, as
described previously (Colomer-Lluch et al., 2014a). To rule out
the possibility of contamination with free DNA outside the phage
particles, an aliquot of the sample taken after DNase treatment
and before desencapsidation was evaluated. At this stage, the
samples were also used as a template for conventional PCR
of eubacterial 16S rDNA (Table 1) and as a template for the
qPCR assay of each ARG. Both amplifications should be negative,
confirming that DNase has removed all non-encapsidated DNA
from the samples.
qPCR Procedures
Eight clinically relevant ARGs that differ in their resistance
mechanisms and clinical significance were evaluated: five
genes that confer resistance to β-lactam antibiotics (blaTEM,
blaCTX−M−1 group, blaCTX−M−9 group blaOXA−48, and blaVIM),
two quinolone resistance genes (qnrA and qnrS) and a gene
conferring resistance to methicillin (mecA), commonly found
in Staphylococcus (Colomer-Lluch et al., 2011b). A fragment of
each target ARG was amplified by conventional PCR using an
Applied Biosystems 2720 Thermal Cycler (Applied Biosystems,
Barcelona, Spain) with the primers described previously (Brown-
Jaque et al., 2018), purified and cloned into a pGEM-T Easy
vector for insertion of PCR products (Promega, Barcelona,
Spain), and used to generate the standard curves as previously
described (Colomer-Lluch et al., 2011b). The standard curves
were constructed with the averaged values obtained by three
replicates in at least five independent serial dilutions of the
standard.
TaqMan qPCR assays (Table 1) were performed under
conditions described previously (Colomer-Lluch et al., 2011b) in
a Step One Real-Time PCR System (Applied Biosystems, Spain).
Genes were amplified in a 20 µl reaction mixture with the
TaqMan R© Environmental Master Mix 2.0 (Applied Biosystems).
The reaction contained 2 or 9µl of the sample DNA or quantified
plasmid DNA.
All the samples, standards used for quantification of
each ARG, positive controls of DNA containing each ARG
and negative controls added to rule out the presence of
non-encapsidated DNA (Colomer-Lluch et al., 2014a) and
contamination of the qPCR reaction, were assayed in duplicate.
The gene copy (GC) was defined as the average of the duplicate
data obtained. The efficiency (E) of all qPCR reactions ranged
from 95 to 100%. To quantify the ARGs we considered the
GC results obtained within the threshold cycle (Ct) within
the limit of quantification (LOQ). This was determined by
the last valid Ct for each ARG assay in the standard curve
that is consistent in the diverse replicates. However, sometimes
amplification was observed beyond the LOQ, but the lack
of consistency in the replicates did not allowed the GC to
be correctly quantified. The values beyond the LOQ but
not undetermined were those within the limit of detection
(LOD).
We designed a new blaVIM qPCR assay for this study.
A 748 bp fragment of the sequence of blaVIM was amplified
from a clinical isolate of P. aeruginosa. by conventional
PCR with primers UP-TCTACATGACCGCGTCTGTC/LP-
TGTGCTTTGACAACGTTCGC. The fragment generated was
cloned in a pGEM vector and used to prepare the standard curve.
A blaVIM qPCR assay (Table 1) was designed with the software
tool Primer Express 3.0 and commercially synthesized (Applied
Biosystems). Specificity was determined via sequence alignments
using blaVIM sequences available in the NCBI nucleotide
database. A FAM-labeled fluorogenic probe was commercially
synthesized by Applied Biosystems. The blaVIM probe was
minor-groove binding (MGB) with an FAM reporter (FAM:
6-carboxyfluorescein) and an NFQ quencher (non-fluorescent
quencher). The blaVIM gene showed an efficiency of 91.9% and a
detection limit of 22.5 GC/µl (Ct of 33.9).
Evaluation of Infectious Phages in the
Samples
Laboratory strain Escherichia coli WG5 (Anonymous, 2000),
S. aureus RN450 (Novick, 1967), an environmental isolate of
P. aeruginosa and Klebsiella pneumoniae reference strain of
capsular serotype K2 (Orskov and Orskov, 1984), were used
as hosts for bacteriophage propagation. These were selected
for their ability to detect lytic phages and were negative for
the ARGs in this study. Phage propagation was performed in
solid culture by double agar layer (Anonymous, 2000) with
some modifications. Briefly, 1 ml of target bacteria grown
in LB at an OD600 of 0.3 was mixed with Luria Bertrani
(LB) semi-solid agar (0.7% agar) supplemented with 6 mM
CaCl2. The mixture was poured into LB agar plates and left
to solidify at room temperature. Ten microliters of each phage
suspension was dropped onto the agar layer and plates were
examined for the presence of lysis after incubation at 37◦C
overnight.
Phage Purification by CsCl Density
Gradients
Sputum samples showing a high level of ARGs in phage DNA
were pooled and used for purification of phages using caesium
chloride (CsCl) density gradients (Sambrook and Russell, 2001).
The easily visible gray bands corresponding to bacteriophages
were collected and dialysed. Phages in the bands were used in
electron microscopy studies and to quantify the presence of ARGs
by qPCR.
Electron Microscopy Studies
Fifteen microliters of phage suspensions purified from
CsCl gradient sputum was deposited on copper grids with
carbon-coated Formvar films and negatively stained with 2%
ammonium molybdate (pH 6.8) for 1.5 min. The samples were
examined in a Jeol 1010 transmission electron microscope
(JEOL USA Inc., Peabody, MA, United States) operating at
80 kV.
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Statistical Analysis
Analysis was carried out using the R software packages (R Core
Team, 2014). An ANOVA test was used and a 5% significance
level was adopted to identify differences in ARG content in phage
DNA between groups of individuals under or over 18 years
of age.
RESULTS
Evaluation of the Protocol for Phage
DNA Recovery From Sputum Samples
Homogenization of the sputum sample in PBS (1:3) (v:v) proved
to be equally as efficient as homogenization in PBS (1:5) (v:v). The
preliminary assays performed to evaluate the recovery of spiked
blaTEM GC showed a recovery of >99% with respect to the stock.
In order to minimize the dilution of the sample, 1:3 was selected
for the study.
Recovery of Stx phage 933W spiked in the samples ranged
from 96.0 to 99.8% in five CF sputum samples, suggesting
that the purification protocol efficiently recovered viral particles
inoculated in the samples.
Occurrence of ARGs in Phage DNA of CF
Sputum Samples: Limit of Detection
Versus Limit of Quantification for
Positive Samples
The LOD is the absolute highest threshold cycle (Ct) generated
that still proves to be amplification of the specific target sequence.
The LOQ is defined as the last valid Ct in the standard curve
that is consistent in the diverse replicates and is used to calculate
the efficiency of each qPCR assay. In our case, Ct-values above
34–35 were close to the borderline of true detection and produced
inconsistent and non-reproducible results among the replicates
due to the low GC numbers.
The results for the different ARGs in the phage fraction
of the sputum samples varied according to whether the LOD
or LOQ was considered (Figure 1). Positive samples within
the LOD showed regular curves but the Ct-values were too
close to the limit and beyond the LOQ defined for our qPCR
assays. As it was impossible to properly calculate the densities
of GC in these cases, only positive samples within the LOQ
are included in the results. However, we consider it worth
noting that some amplification of certain ARGs took place,
which emerge when considering the LOD, and that these
samples were not really negative. This is the case of mecA
and qnrA genes. When considering the LOD, some samples
carried up to seven ARGs, whereas when considering the
LOQ, no more than four ARGs were encountered in the same
sample.
Occurrence of ARG by Age
Sputum samples were taken from 71 CF patients aged 4 to
79 years. Two subgroups were devised: patients under or 18 years
old (n = 28) and above (n = 43) (Figure 2). No remarkable
differences were observed; the only significant (p < 0.05)
FIGURE 1 | Percentage of positive samples for each antibiotic resistance
gene (ARG) in phage DNA of the sputum samples considering the limit of
detection (LOD) or the limit of quantification (LOQ) of the qPCR assays.
differences were a higher percentage of blaTEM and lower
percentage of blaCTX−M−9 group positive samples in the younger
subgroup (Figure 2).
In addition to the 71 sputum samples from CF patients,
sputum samples from 21 healthy individuals not affected by the
disease were analyzed. ARGs in the phage fraction were also
detected in this group. As for CF samples, mecA was not detected
in non-CF individuals. One sample was positive for blaCTX−M−1,
blaOXA−48 and qnrS. qnrA and blaCTX−M−9 were detected in
three and four control samples, respectively, and blaTEM and
blaVIM were the most prevalent with seven and eight positive
samples, respectively.
Abundance of ARGs in Phage DNA of
Sputum of CF Patients
The quantification of ARGs in phage DNA showed that
β-lactamase genes were the most abundant in CF patients, with
values of up to 103 GC/ml (Figure 3). In contrast, there was an
absence of qnrA and mecA, and very low numbers of qnrS. The
highest copy number was obtained for the blaVIM gene with a
mean of 3.1 log10 GC/ml (Figure 3) and a maximum value of 4.6
log10 GC/ml (Figure 3).
Characterization of Bacterial Isolates
and Antibiotic Resistances
The results of the bacterial cultures of the sputum samples
of the CF patients showed that 46.5% were positive for
P. aeruginosa, 39.4% for S. aureus, 7.0% for Achromobacter sp.,
5.6% for Stenotrophomonas maltophilia, 2.9% for H. influenzae,
1.4% for H. parainfluezae and 1.4% for Burkholderia sp.
None of the samples were positive for any species of the
Enterobacteriaceae family. Antimicrobial susceptibility testing
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FIGURE 2 | Percentage of positive samples for each ARG in phage DNA of the sputum samples of individuals aged below 18 years and above 18 years old. Lower
chart shows the distribution of the number of ARGs in phage DNA detected in each individual in relation to age.
showed that 42.4% of the P. aeruginosa isolates obtained
were multidrug-resistant (i.e., non-susceptible to at least one
agent in three or more antimicrobial categories) and of
those, 71.4% were extensively drug-resistant (i.e., susceptible
to only one or two antimicrobial categories). Regarding the
S. aureus isolates obtained, 34.6% of them were methicillin
resistant.
In the non-CF group, 14 of the 21 sputum samples were
analyzed for the presence of bacteria. In five samples S. aureus
was detected (one of them was methicillin resistant) and in one
sample P. aeruginosa was detected. No bacteria were isolated
from the rest of the samples.
When comparing the results of isolates for each sample and
the ARG results in phage DNA, no co-occurrence was found
between ARG in phage DNA and the bacterial species isolated
or their antibiotic susceptibility profiles.
Presence of Infectious Bacteriophages
in the CsCl Purified Samples
The qPCR detection of ARGs in the phage DNA fraction
of sputum samples provided evidence of the presence of
ARGs-mobilizing phage particles. To gain more information,
we further purified the phage particles in the samples to (i)
evaluate their infectivity, (ii) directly visualize them by electron
microscopy, and (iii) confirm that these purified particles
FIGURE 3 | Quantification of ARGs in the phage fraction of sputum samples
from cystic fibrosis patients. Values in brackets indicate the number of positive
samples that were used for the calculation. In the box plot, the cross-pieces
of each box represent (from Top to Bottom) the maximum, upper-quartile,
median (black bar), lower-quartile and minimum values. The black diamond
shows the mean value. The upper gray boxes in the box plot include samples
showing values within the 75th percentile and lower white box samples show
values within the 25th percentile.
propagated in a host strain and observed by electron microscope
carried ARGs.
A pool of phages purified from 10 sputum samples was
used to determine the presence of infectious phages carrying
ARGs by a spot test, as described in section “Materials
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FIGURE 4 | Analysis of infectious phage particles isolated from pooled sputum samples of CF patients. (A) Infectivity of the phages from sputum samples onto
Escherichia coli (Ec), Staphylococcus aureus (Sa), P. aeruginosa (Pa), and K. pneumoniae (Kp) hosts. Gray bands corresponding to density 1.45 g/ml in the tubes of
CsCl density gradients prepared with the phages isolated from the spot test onto each strain (C) qPCR results of the ARGs present in the phage particles purified
from each CsCl density band in (B). (D) Electron micrographs of phage particles purified from the CsCl bands obtained with Pa and Kp samples. Bar 100 nm.
and Methods.” The occurrence of lysis was attributed to
the presence of phages capable of infecting a given strain.
Opaque lysis in the area of the spot test was observed on
the E. coli WG5 host strain (Ec) (Brown-Jaque et al., 2016)
and S. aureus RN450 (Sa) (Novick, 1967), whereas clear lysis
occurred on P. aeruginosa (Pa) and K. pneumoniae (Kp) hosts
(Figure 4A).
To increase the volume of phage suspension, 20 spots of
each strain were pooled together. As a negative control, layers
of each host strain without phages were used. Suspensions were
treated by chloroform, DNAse and further purified by CsCl
gradients.
Thick gray bands at the densities expected for phages
(1.45 g/ml) were obtained for phage suspensions recovered from
Kp and Pa lysis areas. Thin bands at the same density were
obtained from Ec and Sa samples (Figure 4B). No bands were
obtained from the control without phages. DNAs extracted from
phages in each of the bands in Figure 4B were used as a
template for the qPCR quantification of ARGs (Figure 4C).
blaTEM, blaCTX−M−1 group, blaOXA−48, and blaVIM were detected
in densities of up to 105 GC/ml depending on the gene and the
host strain (Figure 4C).
Particles compatible with phage capsid heads were visualized
by electron microscopy in the CsCl bands of Ec and Sa samples,
but the presence of phages could not be confirmed due to the
absence of tails (images not shown). In contrast, capsids of phages
of the Siphoviridae morphological types with isometric heads and
various tail lengths (120–150 nm) were observed in Pa and Kp
samples (Figure 4D). We also observed one apparently detached
Myoviridae tail (210 nm) (Figure 4D, Pa, second row).
DISCUSSION
Phages are among the most recently studied MGEs that play
a role in the spread of ARGs (Colomer-Lluch et al., 2011b;
Fancello et al., 2011; Subirats et al., 2016). In our study, ARGs
were detected in phage particles, as previously observed in
other biomes (Muniesa et al., 2004; Colomer-Lluch et al., 2011b;
Lekunberri et al., 2017; Lood et al., 2017; Brown-Jaque et al., 2018)
and in accordance with metagenomics analyses of CF patients
(Bittar et al., 2008; Fancello et al., 2011). The protocol used
appeared to be sufficiently efficient for our purposes. However, it
should be noted, that CF sputum samples are very dense matrices
and the protocol of inoculation and mixture of phage 933W
may not have achieved a level of phage particle internalization
comparable with that of phage particles already present in
the sample. As a consequence, recovery of naturally occurring
phages, or phage types other than 933W, could be less efficient
than in the spiked samples. In this case, the phage densities in
the real samples would be even higher than our results indicate.
Furthermore, the limits imposed by our qPCR quantification
curve may underestimate the presence of ARGs in some samples,
as revealed when comparing the LOD and LOQ.
Compared to healthy individuals, the far greater viscosity of
the sputum of CF patients could also hinder the extraction of
the packaged DNA, causing an underestimation of the results.
It is also possible that the microorganisms remain more firmly
attached to the lung in CF patients because of the difficulties in
expectoration.
Among all ARGs amplified in this study, the most prevalent
and abundant group are the β-lactamase genes. This is in
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agreement with the widespread expansion of bla genes in the
environment, either in bacterial (Mesa et al., 2006) or phage
fractions (Colomer-Lluch et al., 2011a,b; Marti et al., 2014), in
human (Fancello et al., 2011) and animal biomes (Mesa et al.,
2006; Economou and Gousia, 2015). Notably, a high percentage
of P. aeruginosa isolates from CF patients in our study displayed
resistance to β-lactam antibiotics, in agreement with previous
reports (López-Causapé et al., 2017). A high β-lactamase activity
has also been reported in CF-patients (Giwercman et al., 1992).
In contrast, the mecA gene was almost absent in the phage DNA
fraction of our study, while 35% of the isolates were MRSA, in
agreement with other studies (Muhlebach, 2017).
Analysis of a smaller group of samples from non-CF-patients
also revealed the presence of ARGs, confirming an individual
variability of the microbiome (Hauser et al., 2014). Moreover, the
healthy population has for decades been subjected to antibiotic
pressure and has incorporated ARGs into their microbiomes,
even in the absence of a recent antibiotic treatment (Sommer
et al., 2010; Penders et al., 2013; Quirós et al., 2014; Brown-Jaque
et al., 2018).
An ARG encoded in a bacterial cell can be mobilized by a
phage particle through transduction, or a related mechanism not
yet defined (Quirós et al., 2016). The particle may remain in
a biome where bacteria are no longer present or be mobilized
to a different area. This might explain the apparent lack of
coherence of our results concerning ARGs in packaged DNA
and the bacterial species isolated. We recently demonstrated
that phages present in many human biomes can interfere in the
isolation of bacteria from samples (Brown-Jaque et al., 2016).
This interference could be due to phage infection, propagation
and subsequent lysis of the bacteria targeted for isolation during
the enrichment process. In addition, only a fragment of the
ARG may be detected by qPCR amplification, or the phage
particle might not be carrying the complete gene (Martínez et al.,
2014) and hence be unable to confer resistance. Nevertheless, in
previous studies at least a fraction of ARGs in phage DNA were
complete and able to confer resistance (Colomer-Lluch et al.,
2011b).
Previous evidence from phage fecal environments or studies
of clinical strains suggests that the mobilization of phage-based
ARGs may be mostly by generalized transduction (Monson et al.,
2011). It has been proposed that the frequency of transduction
events could be greater than previously thought (McDaniel et al.,
2010). To the best of our knowledge, the phage particles observed
after propagation on P. aeruginosa and K. pneumoniae allowed us
to visualize phages in sputum samples for the first time.
The high levels of ARGs in the purified infectious phage
particles confirmed that at least some of them harbored ARGs.
The number of phage particles present in Ec and Sa samples
was apparently insufficient to allow their visualization by electron
microscope. Considering that the concentration required for
phage detection by electron microscopy is a minimum of 108
particles/ml (Brown-Jaque et al., 2016), it can be estimated
that a fraction of 1/103–1/105 of the particles observed in
Pa and Kp contained one ARG, a frequency in agreement
with previous studies (McDaniel et al., 2010). The ability of
some bacteriophages to infect different bacteria, strains or even
bacterial genera would facilitate the ARG mobilization in biomes
that contain multiple microorganisms such as the lungs.
One of the most important pathogen is Pseudomonas spp.
(Elborn, 2016). A notably high prevalence of blaVIM has been
found in packaged DNA, an ARG linked to Pseudomonas
infection (Tato et al., 2010). Pseudomonas cells carry a high
number of prophages and generalized transduction has been
extensively reported in this genus (Fothergill et al., 2011; Monson
et al., 2011). Phages of Pseudomonas appear to be polyvalent
and can even infect other bacterial genera (for instance E. coli)
(Yu et al., 2016). In the early stages of the disease, the lungs
are colonized by S. aureus (Bittar et al., 2008; Elborn, 2016),
which displays mobilization of pathogenicity islands (encoding
virulence factors) through helper phages (Novick et al., 2010)
and in S. aureus phages capable of mobilizing ARGs have also
been reported (Novick et al., 2010). Moreover, Burkholderia,
another common lung colonizer in CF patients, is the first non-α
proteobacteria reported to contain gene transfer agents (GTAs),
phage-derived elements encoded in the bacterial chromosome
capable of packaging any sort of bacterial DNA in their phage
capsids (Ronning et al., 2010). GTAs involve a mechanism similar
to generalized transduction (Ronning et al., 2010; Quirós et al.,
2016), in which the DNA of the bacteria carrying the GTA
genes is packaged and spread within the capsids they encode.
Phages and phage-like elements are also common in pathogens
associated with CF, such as Haemophilus (Zehr et al., 2012) or
Mycobacterium (Dedrick et al., 2017).
Most bacteria involved in CF (e.g., Pseudomonas), are
organized, spread and coexist within the biofilm generated in the
lungs of sufferers, which greatly hampers antibiotic treatments.
This is about a cause of concern, considering that bacteriophages
might transfer genes within biofilms (Solheim et al., 2013).
Transduction rates are highly dependent on the density
of bacterial cells and phage particles, and could be increased
by various factors: the immobilization of the donor and
receptor bacteria in the biofilm matrix, the high concentration
of microorganisms in this habitat, and phage induction by
antibiotics, which increases the number of phage particles
(Fothergill et al., 2011). This could represent another difficulty
for the treatment of CF patients, in addition to the antibiotic
diffusion barrier of biofilm.
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